Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Cross-Sectional Study of Quality of Life in Patients Enrolled in the Romanian Hereditary Angioedema Registry. | Cureus | 2024 | 38196989 | PubTator, text mining | PubMed |
| Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients. | Acta Neuropathol Commun | 2024 | 38191511 | PubTator, text mining | PubMed |
| Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications. | Mater Today Bio | 2024 | 38188647 | PubTator, text mining | PubMed |
| Mechanism of anion exchange and small-molecule inhibition of pendrin. | Nat Commun | 2024 | 38184688 | PubTator, text mining | PubMed |
| Comparative Analysis of Molecular Landscape in Mouse Models and Patients Reveals Conserved Inflammation Pathways in Age-Related Macular Degeneration. | Invest Ophthalmol Vis Sci | 2024 | 38175639 | PubTator, text mining | PubMed |
| The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis. | Blood Adv | 2024 | 38175623 | PubTator, text mining | PubMed |
| Loratidine is associated with improved prognosis and exerts antineoplastic effects via apoptotic and pyroptotic crosstalk in lung cancer. | J Exp Clin Cancer Res | 2024 | 38163866 | PubTator, text mining | PubMed |
| Extracellular vesicles from organoid-derived human retinal progenitor cells prevent lipid overload-induced retinal pigment epithelium injury by regulating fatty acid metabolism. | J Extracell Vesicles | 2024 | 38151470 | PubTator, text mining | PubMed |
| Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema. | J Allergy Clin Immunol Pract | 2024 | 38142864 | PubTator, text mining | PubMed |
| Serum proteomic panel validated for prediction of knee osteoarthritis progression. | Osteoarthr Cartil Open | 2024 | 38116469 | PubTator, text mining | PubMed |
| Increased contact activated endogenous thrombin potential in pregnant women with preeclampsia. | Blood Coagul Fibrinolysis | 2024 | 38051647 | PubTator, text mining | PubMed |
| Position-specific N- and O-glycosylation of the reactive center loop impacts neutrophil elastase-mediated proteolysis of corticosteroid-binding globulin. | J Biol Chem | 2024 | 38042488 | PubTator, text mining | PubMed |
| Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema. | J Allergy Clin Immunol Glob | 2024 | 38033485 | PubTator, text mining | PubMed |
| Screening for type II hereditary angioedema-the "poor man's c1-inhibitor function". | J Allergy Clin Immunol Glob | 2024 | 38026504 | PubTator, text mining | PubMed |
| Complement in human disease: approved and up-and-coming therapeutics. | Lancet | 2024 | 37979593 | PubTator, text mining | PubMed |
| Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle. | Clin Transl Oncol | 2024 | 37783922 | PubTator, text mining | PubMed |
| Tackling the Root Cause of Surface-Induced Coagulation: Inhibition of FXII Activation to Mitigate Coagulation Propagation and Prevent Clotting. | Macromol Biosci | 2024 | 37742317 | PubTator, text mining | PubMed |
| Patient-level indirect treatment comparison of lanadelumab versus pdC1-INH i.v. in hereditary angioedema patients: PATCH study. | Allergy | 2024 | 37641968 | PubTator, text mining | PubMed |
| Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation. | Semin Thromb Hemost | 2024 | 36417927 | PubTator, text mining | PubMed |
| Functional Characterization of Two Novel Intron 4 SERPING1 Gene Splice Site Pathogenic Variants in Families with Hereditary Angioedema. | Biomedicines | 2023 | 38255179 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=17